Puma Biotechnology Financials

Puma Biotechnology Stock Summary

Puma Biotechnology competes with Ultragenyx, Crinetics Pharmaceuticals, Arvinas, Revolution Medicines, and Kura Oncology. Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company was founded in 2010 and is headquartered in Los Angeles, California. Puma Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.

Puma Biotechnology Key Financial Ratios

Puma Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Puma Biotechnology's current stock value. Our valuation model uses many indicators to compare Puma Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Puma Biotechnology competition to find correlations between indicators driving Puma Biotechnology's intrinsic value. More Info.Puma Biotechnology is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.21  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Puma Biotechnology is roughly  4.77 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Puma Biotechnology's earnings, one of the primary drivers of an investment's value.

Puma Biotechnology Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Puma Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Puma Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Puma Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Puma Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Puma Biotechnology's daily price indicators and compare them against related drivers.

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.